Latest Federal & Government Contracting Companies' News Coverage
Hologic has received a one-year, $4.1 million contract from the Department of Health and Human Services to further develop a test that works to detect Zika virus in donated blood. The company’s Procleix Zika Virus Assay is designed to detect for up to seven days the presence of ribonucleic acid linked to the mosquito-borne virus […] More
Avita Medical has received $7.96 million in additional funds from the Biomedical Advanced Research and Development Authority to continue efforts to launch a regenerative medicine product and obtain U.S. market approval. The company will use the new funds to help U.S. Burn Centers familiarize themselves with health economic models of ReCell’s usage and potential application in the treatment of burns, Avita […] More
Medical device manufacturer Terumo BCT has received $17.4 million in initial funds from the Biomedical Advanced Research and Development Authority to conduct a clinical trial on a technology intended to help facilitate platelet treatments in patients. Terumo BCT said Tuesday its Pathogen Reduction Technology system designed to study the clinical effectiveness of standard platelets in plasma compared to Mirasol-treated platelets in plasma for patients […] More
The Centers for Innovation in Advanced Development and Manufacturing has received an 18-month, $10.49 million task order from the Department of Health and Human Services to help the agency develop a second-generation anthrax vaccine. CIADM is located at Texas A&M University in College Station will support development of Altimmune‘s NasoShield anthrax vaccine candidate that is meant to be […] More
Pharmaceutical Product Development will provide research and development and vaccine services to the U.S. Army and the Biomedical Advanced Research and Development Authority as part of two new contracts. The company said Thursday it will support Army R&D activities that work toward force readiness, improved health outcomes and the delivery of high-quality medical and preventative care to deployed service members […] More
Regeneron Pharmaceuticals has landed a potential 23-month, $38 million contract from the U.S. Department of Health and Human Services to further develop the company’s experimental drug against Ebola virus. HHS’ Biomedical Advanced Research and Development Authority could provide $11.3 million in additional funds for Regeneron to produce alternative anti-Ebola monoclonal antibody drugs for clinical research […] More
AstraZeneca and the Department of Health and Human Services have signed a partnership agreement on the development of antibiotics for drug-resistant infections and potential bioterrorism threats. HHS said Wednesday the public-private partnership also includes a cost-sharing deal in which the department’s Biomedical Advanced Research and Development Authority will contribute up to $170 million over a five-year period. “This agreement demonstrates our […] More
Crucell Holland will move forward with work to develop experimental vaccine regimen for Ebola under a potential seven-year, $69 million contract with the preparedness and response unit of the Department of Health and Human Services. HHS said Monday the Netherlands-based pharmaceutical company will work with Denmark-based Bavarian Nordic to develop the Ad26.ZEBOV prime and MVA-BN-Filo boost components of the regimen. The […] More
Pfenex Inc. and the Department of Health and Human Services have begun  clinical research for a new anthrax vaccine under a 30-month, $15.9 million contract. The Biomedical Advanced Research and Development Authority will lead the project to develop the experimental vaccines Px563L and RPA563, which target the anthrax cell-binding protein, HHS said Monday. “It is paramount to […] More
The Emergent BioSolutions-led Center for Innovation in Advanced Development and Manufacturing will continue the development of a therapeutic drug against Ebola under a new two-year, $19.7 million contract with the Department of Health and Human Services. HHS said Wednesday the Emergent CIADM facility will begin advanced work to manufacture a monoclonal antibody drug as part of its public-private […] More
SRI International has received a $12.2 million contract from the Biomedical Advanced Research and Development Authority to extend the company’s work on the development of a screening device for radiation exposure. David Cooper, director of the sensor systems laboratory at SRI, worked with DCN Diagnostics, Evolve Manufacturing and Stanford University’s School of Medicine five years ago to […] More
BioCryst Pharmaceuticals will experiment on a new drug to treat the Ebola virus under a potential $35 million contract with the Department of Health and Human Services. Studies on the experimental drug will occur over the next 18 months in collaboration with the Biomedical Advanced Research and Development Authority prior to large-scale production, HHS said Tuesday. […] More
